Engineering Immune Cells to Realize the Promise of Cancer Cell Therapies

 In this Q&A, Luminary Therapeutics' Beau Webber, Ph.D., discusses the company’s vision to fuse good science and smart business to help drive the future of cell therapy for treating cancer.

    • Tags:

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

Q: